Translation Services and the Race for a Coronavirus Vaccine
With hundreds of coronavirus clinical studies underway, what role does the language industry play in facilitating the search for a vaccine? Where does linguistic validation fit in?
life science translations
GLS Founders Cash Out, Sell to Welocalize
Welocalize doubles down on life sciences, buys Global Language Solutions in acquisition number 17. Along with recently acquired Nova and Park IP, CEO Smith Yewell will fold GLS into a newly formed “regulated industries” business unit.
Vaccinate the Interpreter: Britain’s Health Service in RFP Worth Up to GBP 80m
Following the playbook of the Crown Commercial Service and the Ministry of Justice, Britain’s NHS launches a tender for translation and interpretation services for the whole of England. Among the requirements: proof that interpreters are vaccinated against tuberculosis and other diseases.
Steady as She Goes: Profits, Revenues Up as RWS Reports Half-year Results
The most valuable publicly listed language service provider RWS reports another uptick in revenues and profit; gears up to battle it out for global life sciences and CRO accounts leveraging recently acquired CTi.
RWS to Pay Full USD 70m as CTi 2015 Profit Nearly Doubles
RWS chairman says CTi nearly doubled EBITDA in 2015 to no less than USD 8.5m, topping target that triggers full USD 70m acquisition price. RWS “significantly ahead of expectations” in Q4 2015.
Your information will not be shared with third parties. No Spam.